MY01, a Montreal, Canada-based medical technology company, raised $12.5M in funding.
The round was led by Investissement Quebec, with participation from Desjardins Capital and Fondaction.
The company intends to use the funds to expand commercialization activities in the United States.
Led by CEO Charles Allan, MY01 provides a Continuous Compartmental Pressure Monitor (CCPM) that aids in the diagnosis of compartment syndrome, a medical condition where pressure increases inside a muscle, which restricts blood flow and causes pain. The MY01 CCPM embeds a microsensor into the compartment and translates continuous pressure data to both a monitor and a mobile app.
FinSMEs
11/04/2023